Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Quetiapine may cause hair loss, a side effect not widely recognized before.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.